Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL

Conditions: Non-hodgkin Lymphoma,B Cell Interventions: Biological: Allogeneic CD19-STAR T cell; Drug: Fludarabine; Drug: Cyclophosphamide Sponsors: Chinese PLA General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials